We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 105.97 | 54 | 09:01:24 |
From May 2021 to May 2024
By Matt Grossman
Abbott Laboratories Wednesday raised its full-year adjusted-earnings guidance, after revenue from Covid-19 testing helped lift its diagnostics business sales 48% in the third quarter.
The Abbott Park, Ill.-based medical-products company forecast adjusted earnings per share of $5.00 to $5.10 for the year. In July, Abbott was guiding for per-share adjusted earnings of $4.30 a share to $4.50 a share.
Analysts had expected full-year adjusted earnings of $4.46 a share, according to FactSet.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 20, 2021 08:02 ET (12:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
